US3441741077
US3441741077
Foghorn Therapeutics Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 30.909.000 | 22.602.000 | 36.8% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 113.016.000 | 122.887.000 | 8.0% | |
| Operating Income | -82.107.000 | -100.285.000 | 18.1% |
| Pretax Income | -74.283.000 | -86.620.000 | 14.2% |
| Net Income Common Stockholders | -74.283.000 | -86.620.000 | 14.2% |
| -- | -- | -- | |
| -- | -- | -- |